tirzepatide effect on cholesterol does reduce Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide Frontiers | Bile acids and

Censuswide is a member of the Market Research Society (MRS) and the British Polling Council (BPC), and a signatory of the Global Data Quality Pledge

No definitive peer-reviewed study has yet proven causation, though patient reports and preliminary analyses deserve attention

Similarly, the SUSTAIN-6 trial, which enrolled patients with T2DM and either established CVD, stage 3 chronic kidney disease, or age 60 with risk factors, showed that semaglutide reduced MACE by 26% (HR 0.74), primarily driven by a 39% reduction in non-fatal stroke (19)

Semaglutide improves type 2 diabetes glucose management

To put it in perspective: Semaglutide (Ozempic) is like the original iPhone groundbreaking in its time